This article is more than 5 years old. Information may no longer be current.

FDA approves new lumbar surgery system

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Captiva Spine. Inc. received 510(k) clearance from the FDA to market the TowerLOX Minimally Invasive Lumbar Surgery System.

According to a company press release, the TowerLOX Minimally Invasive Lumbar Surgery System provides simple and intuitive function in a cannulated pedicle screw, tower and rod delivery system. Complemented with a proprietary rod delivery system, the PivoRod allows the surgeon control during percutaneous rod insertion, and the purposely designed mechanism for screw extensions ensures simple assembly and disassembly to the polyaxial screw.

“The FDA clearance of this new system is an important milestone for Captiva Spine,” Dale Mitchell, president and founder of Captiva, stated in the release. “This system clearly demonstrates our ability to provide innovative solutions through collaboration with industry experts, surgeons and Captiva’s quality and engineering team.”